Stay updated on FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases
Sign up to get notified when there's something new on the FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases page.

Latest updates to the FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases page
- ChecktodayChange DetectedNo significant additions or deletions were observed on the Study Details page; the core content and structure appear unchanged.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check30 days agoChange DetectedKey updates include a status notice about government funding and the NIH Clinical Center operating status, a new revision tag v3.2.0, and the addition of 'Chronic mucocutaneous candidiasis'; the previous version v3.1.0 was removed.SummaryDifference2%

- Check37 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. No other substantive changes to core content, pricing, stock, or time-slot information.SummaryDifference0.1%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

- Check66 days agoChange DetectedThe web page has been updated to include new drug information for Ibrexafungerp and additional resources related to various diseases, while removing outdated location details and previous disease information.SummaryDifference5%

Stay in the know with updates to FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases
Enter your email address, and we'll notify you when there's something new on the FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases page.